Guardant Health
GH
#1101
Rank
โ‚ฌ19.42 B
Marketcap
143,61ย โ‚ฌ
Share price
3.00%
Change (1 day)
69.50%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2023 (TTM): -4,69ย โ‚ฌ

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -3,13ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -5,74ย โ‚ฌ a decrease over its 2021 EPS that were of -3,59ย โ‚ฌ.

EPS history for Guardant Health from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-4,69ย โ‚ฌ-18.29%
2022-5,74ย โ‚ฌ60%
2021-3,59ย โ‚ฌ55.04%
2020-2,32ย โ‚ฌ207.14%
2019-0,75ย โ‚ฌ-19.81%
2018-0,94ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-0,23ย โ‚ฌ-92.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-2,20ย โ‚ฌ-29.80%๐Ÿ‡บ๐Ÿ‡ธ USA